Analyst Ratings February 24, 2026

Evercore ISI lifts FedEx price target to $380, citing firmer demand and cost leverage

Analyst tweaks EPS forecasts after investor day and fresh macro datapoints; stock already trading above the new target

By Derek Hwang FDX
Evercore ISI lifts FedEx price target to $380, citing firmer demand and cost leverage
FDX

Evercore ISI raised its price target on FedEx to $380 from $364 while retaining an In Line rating, updating near-term EPS estimates after the company's investor day and new macroeconomic inputs. The firm cites an improving demand backdrop, continued pricing and cost discipline at FedEx, and modeling adjustments that incorporate delayed data from a recent U.S. government shutdown and China’s Lunar New Year.

Key Points

  • Evercore ISI raised its FedEx price target to $380 from $364 and kept an In Line rating.
  • The firm updated fiscal Q3 2026, FY2026, and FY2027 EPS estimates and raised calendar year 2027 EPS to $23.74, the basis for the new target.
  • FedEx declared a $1.45 quarterly cash dividend payable April 1, 2026, and is joining a consortium to invest $2.6 billion in acquiring InPost; other analysts have raised price targets and reiterated confidence in FedEx’s financial goals.

Summary: Evercore ISI increased its one-year price objective for FedEx to $380 from $364 and kept an In Line rating. The firm revised fiscal third quarter 2026, fiscal year 2026, and fiscal year 2027 earnings-per-share estimates after FedEx’s recent investor day and the arrival of new macroeconomic data. Those changes reflect what Evercore ISI describes as a stronger demand environment, ongoing favorable pricing and cost initiatives at the company, and model adjustments to account for delayed economic inputs.

FedEx shares are trading at $383.71, which is already above the newly set $380 target and close to the 52-week high of $391.65. Evercore ISI updated its forecasts against that market backdrop, increasing its calendar year 2027 EPS estimate to $23.74 and citing that projection as the basis for the $380 price target.

The analyst firm said it refined its near-term estimates after incorporating information from the company’s investor day held two weeks ago, together with recent macroeconomic data points. Evercore ISI pointed to an improving demand backdrop and continued favorable pricing and cost initiatives at FedEx as the primary drivers behind the estimate changes.

Evercore ISI also noted that two recent events temporarily disrupted some of the inputs to its macroeconomic models: the latest U.S. government shutdown and China’s Lunar New Year. Those interruptions delayed certain January and February data series. To address the gaps, the firm extrapolated from the most recent available data and introduced new correlation work into its modeling process.

According to Evercore ISI, several parts of the global demand picture have firmed, specifically China exports and retail sales, while the drag from industrial production has diminished. When combined with an extrapolation of FedEx’s recent yield momentum and ongoing cost controls, these factors generate what the firm describes as meaningful operating leverage inside its model.

Market performance has been strong: the stock has returned 54.9% over the past year and shows a year-to-date gain of 32.8%. The firm’s note also references an InvestingPro analysis that indicates the shares may be overvalued at current levels relative to its Fair Value estimate.

Evercore ISI signaled it is likely to publish another preview of the fiscal third quarter ahead of FedEx’s March 19 earnings release as additional macroeconomic data becomes available.


Recent corporate actions and peer analyst moves

Separately, FedEx declared a quarterly cash dividend of $1.45 per share, payable on April 1, 2026, to shareholders of record as of March 9, 2026. Evercore ISI noted the dividend remains consistent with previous quarters.

FedEx is also participating in a consortium to acquire InPost, a European delivery provider, with a $2.6 billion investment. Bernstein SocGen Group has expressed support for the deal and reiterated an Outperform rating along with a $427.00 price target on FedEx.

Other analysts have adjusted their views recently as well. Truist Securities raised its price target to $400, citing a robust earnings framework for 2029. Stephens lifted its target to $405 following strategic takeaways from the company’s investor day. Bernstein SocGen Group highlighted FedEx’s targets of reaching $25 earnings per share by 2029 and generating $16 billion in free cash flow over the next three years, framing these targets as reasons for its continued Outperform stance.


Outlook

Evercore ISI’s update ties its higher target to an improved demand outlook, continued pricing power and cost discipline at FedEx, and modeling adjustments made to compensate for delayed macro data. The firm’s willingness to publish another preview prior to the March 19 earnings release indicates it expects further clarity from incoming economic releases.

Risks

  • Delayed macroeconomic data - The recent U.S. government shutdown and China’s Lunar New Year disrupted January and February inputs, requiring extrapolation and new correlation work that may introduce uncertainty into forecasts. This affects macro-sensitive sectors including transportation and industrials.
  • Valuation concerns - While the stock has posted strong returns (54.9% over one year; 32.8% YTD), InvestingPro analysis suggests shares may be overvalued relative to Fair Value, presenting market-risk for equity investors in logistics and broader market indices.
  • Execution and integration risk - FedEx’s participation in the consortium to acquire InPost and the pursuit of strategic targets like $25 EPS by 2029 and $16 billion in free cash flow carry execution and integration risks that could affect the transportation and European parcel sectors.

More from Analyst Ratings

Needham Trims EverQuote Price Target After Softer Q1 Guidance; Buy Rating Stands Feb 24, 2026 Needham Lowers Backblaze Price Target as Software Multiples Compress Feb 24, 2026 FBN Securities Starts Coverage of SailPoint With Outperform, Sees Upside From Identity Platform Feb 24, 2026 Needham Lifts Vir Biotechnology Price Target After Promising Phase 1 VIR-5500 Data Feb 24, 2026 Wedbush Lowers Gossamer Bio Rating After PROSERA Miss; Forecasts Steeper Risks Feb 24, 2026